Bioniz

Bioniz

Bioniz

We are an emerging biotechnology company that is fundamentally changing the treatment of diseases driven by dysregulations of the immune system.
Founded
2009
Raised
$13.6M
Follow us
Alexa global traffic share
Latest funding
$13,000,000
Venture capital (Series A) - 2016
Signatures Capital Cota Capital Takeda Ventures +1
$599,205
Seed fund - 2013
Team Size
1–10
Employees
$13,000,000 Venture capital (Series A)
socalTECH.com , sec

Bioniz Therapeutics Raises $13M In Funding Round

Funding Health